Amdl
Amdl notified by Amex of the need to satisfy continued listing standards
Published in Law and Health Weekly, August 26th, 2006
Amdl, Inc., (ADL), developer and marketer of tests for the early detection of cancer and other serious diseases, reported that on July 17, 2006 it received a letter from the American Stock Exchange stating that Amdl has made a reasonable demonstration of its ability to regain compliance with the Amex continued listing standards, and based on that demonstration, the Amex is prepared to continue the listing of Amdl's common stock subject to certain conditions.
On April 26, 2006, the Amex sent a letter to Amdl stating that based on a review of Amdl's Form 10-KSB for the year ended December 31, 2005, Amdl did not meet certain of the Amex's continued listing standards as set...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Law and Health Weekly
More Articles from Law and Health Weekly
- Biomedical Primate Research Center, Rijswijk, Netherlands
Relative neutralization sensitivity/resistance is HIV-1 type B isolate reproducible property - Biosite
Biosite notes 45% increase in sales of cardiovascular products - Community Education Centers
Community Education Centers comments on National Institute on Drug Abuse report - Hannover Medical School, Germany
Hematopoietic stem cells provide protection against HIV infection - Louisiana State University, U.S.
CD8+ T cells in oral lesions of HIV patients are normal activated T cells - National Council for Community Behavioral Healthcare
Community mental health system reports $304 million in uncompensated costs on Medicare drug benefit - More from this issue of Law and Health Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
